论文部分内容阅读
AIM To assess the impact of hepatitis B surface(HBsAg)seroclearance on survival outcomes in hepatitis B-related primary liver cancer.METHODS Information from patients with hepatitis B-related liver cancer admitted in our hospital from 2008-2017 was retrie